Contrast-enhanced ultrasound with SonoVue could accurately assess the renal microvascular perfusion in diabetic kidney damage

Nephrology Dialysis Transplantation

Volumn 27, Issue 7, 2012, Pages 2891-2898

  Ma, Fang ^a   Cang, Yanqin ^a   Zhao, Baozhen ^b   Liu, Yuanyuan ^a   Wang, Chaoqing ^a   Liu, Bo ^a   Wu, Tianfu ^a   Song, Yaxiang ^a   Peng, Ai ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

contrast enhanced ultrasound; diabetes; perfusion; renal impairment; SonoVue

Indexed keywords

SONOVUE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CHI SQUARE TEST; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIAGNOSTIC IMAGING; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; KIDNEY CORTEX; KIDNEY PERFUSION; KIDNEY VEIN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENAL ARTERY; ULTRASOUND;

ADULT; AGED; CASE-CONTROL STUDIES; CONTRAST MEDIA; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; MALE; MIDDLE AGED; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; ULTRASONOGRAPHY;

EID: 84864401042     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr789     Document Type: Article

References (25)

1. Del Prete D, Anglani F, Ceol M et al. Molecular biology of diabetic glomerulosclerosis. Nephrol Dial Transplant 1998; 13Suppl 820-25.
2. Marcelli M. Nutrition in diabetic nephropathy. G Ital Nefrol 2006; 23Suppl 34S68-S70.
3. Dragovic T, Ajdinovic B, Hrvacevic R et al. Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate. Vojnosanit Pregl 2010; 67: 273-278.
4. Kouri TT, Viikari JS, Mattila KS et al. Microalbuminuria. Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients. Diabetes Care 1991; 14: 591-593.
5. Pradeepa R, Anjana RM, Unnikrishnan R et al. Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes-the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5. Diabetes Technol Ther 2010; 12: 755-761.
6. Itoh Y. Current topics on urinary proteins: human albumin, protein 1, beta 2-microglobulin, and type IV collagen. Rinsho Byori 2002; 50: 555-560.
7. Duarte D, Santos-Araujo C, Leite-Moreira AF. Hypertension and angiogenesis in the aging kidney: a review. Arch Gerontol Geriatr 2011; 52: e93-e102.
8. Molitoris BA. Transitioning to therapy in ischemic acute renal failure. J Am Soc Nephrol 2003; 14: 265-267.
9. Okada M, Hoffmann CW, Wolf KJ et al. Bolus versus continuous infusion of microbubble contrast agent for liver US: initial experience. Radiology 2005; 237: 1063-1067.
10. Seitz K, Strobel D, Bernatik T et al. Contrast-Enhanced Ultrasound (CEUS) for the characterization of focal liver lesions-prospective comparison in clinical practice: CEUS vs. CT (DEGUM multicenter trial). Parts of this manuscript were presented at the Ultrasound Dreilandertreffen 2008, Davos. Ultraschall Med 2009; 30: 383-389.
11. Xu ZF, Xu HX, Xie XY et al. Renal cell carcinoma and renal angiomyolipoma: differential diagnosis with real-time contrast-enhanced ultrasonography. J Ultrasound Med 2010; 29: 709-717.
12. Hoeffel C, Pousset M, Timsit MO et al. Radiofrequency ablation of renal tumours: diagnostic accuracy of contrast-enhanced ultrasound for early detection of residual tumour. Eur Radiol 2010; 20: 1812-1821.
13. Benozzi L, Cappelli G, Granito M et al. Contrast-enhanced sonography in early kidney graft dysfunction. Transplant Proc 2009; 41: 1214-1215.
14. Bertolotto M, Martegani A, Aiani L et al. Value of contrast-enhanced ultrasonography for detecting renal infarcts proven by contrast enhanced CT. A feasibility study. Eur Radiol 2008; 18: 376-383.
15. Ascenti G, Mazziotti S, Zimbaro G et al. Complex cystic renal masses: characterization with contrast-enhanced US. Radiology 2007; 243: 158-165.
16. K/doqi clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 392 Suppl 1S1-S266.
17. Kelly KJ, Burford JL, Dominguez JH. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy. Am J Physiol Renal Physiol 2009; 297: F923-F931.
18. Hosotani Y, Takahashi N, Kiyomoto H et al. A new method for evaluation of split renal cortical blood flow with contrast echography. Hypertens Res 2002; 25: 77-83.
19. Tiemann K, Schlosser T, Pohl C et al. Are microbubbles free flowing tracers through the Myocardium? Comparison of indicator-dilution curves obtained from dye dilution and echo contrast using harmonic power Doppler imaging. Echocardiography 2000; 17: 17-27.
20. Siracusano S, Bertolotto M, Ciciliato S et al. The current role of contrast-enhanced ultrasound (CEUS) imaging in the evaluation of renal pathology. World J Urol 2011; 29: 633-638.
21. Correas JM, Claudon M, Tranquart F et al. The kidney: imaging with microbubble contrast agents. Ultrasound Q 2006; 22: 53-66.
22. Fischer T, Filimonow S, Dieckhofer J et al. Improved diagnosis of early kidney allograft dysfunction by ultrasound with echo enhancer-a new method for the diagnosis of renal perfusion. Nephrol Dial Transplant 2006; 21: 2921-2929.
23. Broillet A, Hantson J, Ruegg C et al. Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies. Acad Radiol 2005; 12Suppl 1S28-S33.
24. Cosgrove D, Lassau N. Imaging of perfusion using ultrasound. Eur J Nucl Med Mol Imaging 2010; 37Suppl 1S65-S85.
25. Kay DH, Mazonakis M, Geddes C et al. Ultrasonic microbubble contrast agents and the transplant kidney. Clin Radiol 2009; 64: 1081-1087.